Cargando…

Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients

PURPOSE: This research aimed to identify independent risk factors for hyperuricemia (HUA) in diabetic kidney disease (DKD) patients and develop an HUA risk model based on a retrospective study in Ningbo, China. PATIENTS AND METHODS: Six hundred and ten DKD patients attending the two hospitals betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Guoqing, Li, Mingcai, Mao, Yushan, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627221/
https://www.ncbi.nlm.nih.gov/pubmed/36339149
http://dx.doi.org/10.3389/fpubh.2022.863064
_version_ 1784822917926748160
author Huang, Guoqing
Li, Mingcai
Mao, Yushan
Li, Yan
author_facet Huang, Guoqing
Li, Mingcai
Mao, Yushan
Li, Yan
author_sort Huang, Guoqing
collection PubMed
description PURPOSE: This research aimed to identify independent risk factors for hyperuricemia (HUA) in diabetic kidney disease (DKD) patients and develop an HUA risk model based on a retrospective study in Ningbo, China. PATIENTS AND METHODS: Six hundred and ten DKD patients attending the two hospitals between January 2019 and December 2020 were enrolled in this research and randomized to the training and validation cohorts based on the corresponding ratio (7:3). Independent risk factors associated with HUA were identified by multivariable logistic regression analysis. The characteristic variables of the HUA risk prediction model were screened out by the least absolute shrinkage and selection operator (LASSO) combined with 10-fold cross-validation, and the model was presented by nomogram. The C-index and receiver operating characteristic (ROC) curve, calibration curve and Hosmer–Lemeshow test, and decision curve analysis (DCA) were performed to evaluate the discriminatory power, degree of fitting, and clinical applicability of the risk model. RESULTS: Body mass index (BMI), HbA1c, estimated glomerular filtration rate (eGFR), and hyperlipidemia were identified as independent risk factors for HUA in the DKD population. The characteristic variables (gender, family history of T2DM, drinking history, BMI, and hyperlipidemia) were screened out by LASSO combined with 10-fold cross-validation and included as predictors in the HUA risk prediction model. In the training cohort, the HUA risk model showed good discriminatory power with a C-index of 0.761 (95% CI: 0.712–0.810) and excellent degree of fit (Hosmer–Lemeshow test, P > 0.05), and the results of the DCA showed that the prediction model could be beneficial for patients when the threshold probability was 9–79%. Meanwhile, the risk model was also well validated in the validation cohort, where the C-index was 0.843 (95% CI: 0.780–0.906), the degree of fit was good, and the DCA risk threshold probability was 7–100%. CONCLUSION: The development of risk models contributes to the early identification and prevention of HUA in the DKD population, which is vital for preventing and reducing adverse prognostic events in DKD.
format Online
Article
Text
id pubmed-9627221
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96272212022-11-03 Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients Huang, Guoqing Li, Mingcai Mao, Yushan Li, Yan Front Public Health Public Health PURPOSE: This research aimed to identify independent risk factors for hyperuricemia (HUA) in diabetic kidney disease (DKD) patients and develop an HUA risk model based on a retrospective study in Ningbo, China. PATIENTS AND METHODS: Six hundred and ten DKD patients attending the two hospitals between January 2019 and December 2020 were enrolled in this research and randomized to the training and validation cohorts based on the corresponding ratio (7:3). Independent risk factors associated with HUA were identified by multivariable logistic regression analysis. The characteristic variables of the HUA risk prediction model were screened out by the least absolute shrinkage and selection operator (LASSO) combined with 10-fold cross-validation, and the model was presented by nomogram. The C-index and receiver operating characteristic (ROC) curve, calibration curve and Hosmer–Lemeshow test, and decision curve analysis (DCA) were performed to evaluate the discriminatory power, degree of fitting, and clinical applicability of the risk model. RESULTS: Body mass index (BMI), HbA1c, estimated glomerular filtration rate (eGFR), and hyperlipidemia were identified as independent risk factors for HUA in the DKD population. The characteristic variables (gender, family history of T2DM, drinking history, BMI, and hyperlipidemia) were screened out by LASSO combined with 10-fold cross-validation and included as predictors in the HUA risk prediction model. In the training cohort, the HUA risk model showed good discriminatory power with a C-index of 0.761 (95% CI: 0.712–0.810) and excellent degree of fit (Hosmer–Lemeshow test, P > 0.05), and the results of the DCA showed that the prediction model could be beneficial for patients when the threshold probability was 9–79%. Meanwhile, the risk model was also well validated in the validation cohort, where the C-index was 0.843 (95% CI: 0.780–0.906), the degree of fit was good, and the DCA risk threshold probability was 7–100%. CONCLUSION: The development of risk models contributes to the early identification and prevention of HUA in the DKD population, which is vital for preventing and reducing adverse prognostic events in DKD. Frontiers Media S.A. 2022-10-19 /pmc/articles/PMC9627221/ /pubmed/36339149 http://dx.doi.org/10.3389/fpubh.2022.863064 Text en Copyright © 2022 Huang, Li, Mao and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Huang, Guoqing
Li, Mingcai
Mao, Yushan
Li, Yan
Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
title Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
title_full Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
title_fullStr Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
title_full_unstemmed Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
title_short Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
title_sort development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627221/
https://www.ncbi.nlm.nih.gov/pubmed/36339149
http://dx.doi.org/10.3389/fpubh.2022.863064
work_keys_str_mv AT huangguoqing developmentandinternalvalidationofariskmodelforhyperuricemiaindiabetickidneydiseasepatients
AT limingcai developmentandinternalvalidationofariskmodelforhyperuricemiaindiabetickidneydiseasepatients
AT maoyushan developmentandinternalvalidationofariskmodelforhyperuricemiaindiabetickidneydiseasepatients
AT liyan developmentandinternalvalidationofariskmodelforhyperuricemiaindiabetickidneydiseasepatients